Long-term treatment options for postmenopausal osteoporosis: results of recent clinical studies of Denosumab

Long-term treatment options for postmenopausal osteoporosis: results of recent clinical studies of Denosumab

Modern medications for osteoporosis (bisphosphonates, denosumab, teriparatide) are well-tolerated drugs, which can significantly lower vertebral and non-vertebral fracture risk according to prospective and observational studies in up to 10-year period. Certain drugs (denosumab, teriparatide) are act...

Full description

Bibliographic Details
Main Authors: Zhanna E. Belaya, John P. Bilezikian, Olga B. Ershova, Olga M. Lesnyak, Larisa A. Marchenkova, Svetlana S. Rodionova, Liudmila Y. Rozhinskaya, Natalia V. Toroptsova, Svetlana V. Yureneva
Format: Article
Language:English
Published: Endocrinology Research Centre 2018-04-01
Series:Остеопороз и остеопатии
Subjects:
osteoporosis
bone fracture
denosumab
bisphosphonates
expert opinion
Online Access:https://osteo-endojournals.ru/osteo/article/viewFile/9760/7283

Similar Items

Similar Items